• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    FASTING CANCER
    June 1, 2022
    ENLARGED HEART AND CARDIOMEGALY
    June 1, 2022
    1. Human monkeypox
    2. Human monkeypox: an emerging zoonosis
    3. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures
    4. Human monkeypox, 1970-79
    5. Human monkeypox: clinical features of 282 patients
    6. The detection of monkeypox in humans in the Western Hemisphere
    7. Reemergence of human monkeypox in Nigeria, 2017
    8. A tale of two clades: monkeypox viruses
    9. Human monkeypox
    10. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997.
    11. Human monkeypox: confusion with chickenpox.
    12. Two cases of monkeypox imported to the United Kingdom, September 2018
    13. Human monkeypox: an emerging zoonotic disease
    14. Human monkeypox: a study of 2,510 contacts of 214 patients
    15. Emergence of monkeypox—west and central Africa, 1970–2017
    16. monkeypox transmission and pathogenesis in prairie dogs
    17. The transmission potential of monkeypox virus in human populations
    18. Clinical characteristics of human monkeypox, and risk factors for severe disease
    19. Re-emergence of human monkeypox in Zaire in 1996.
    20. monkeypox virus: ecology and public health significance
    21. Human monkeypox: secondary attack rates
    22. Re-emergence of monkeypox in Africa: a review of the past six years
    23. monkeypox virus
    24. Emergence of monkeypox as the most important orthopoxvirus infection in humans
    25. Diagnosis of imported monkeypox, Israel, 2018
    26. Endemic human monkeypox, democratic Republic of Congo, 2001–2004
    27. The role of squirrels in sustaining monkeypox virus transmission.
    28. Clinical manifestations of human monkeypox influenced by route of infection
    29. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo
    30. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation
    31. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report
    32. Analysis of the monkeypox virus genome
    33. Status of human monkeypox: clinical disease, epidemiology and research
    34. Human monkeypox.
    35. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018
    36. Detection of monkeypox virus with real-time PCR assays
    37. Ecological niche and geographic distribution of human monkeypox in Africa
    38. monkeypox: an emerging infection for humans?
    39. Modelling human-to-human transmission of monkeypox
    40. Update: multistate outbreak of monkeypox–Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003
    41. Discovery of monkeypox in Sudan
    42. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa.
    43. Isolation of monkeypox virus from wild squirrel infected in nature.
    44. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo
    45. Multistate outbreak of monkeypox–Illinois, Indiana, and Wisconsin, 2003
    46. Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus
    47. Human monkeypox infection: a family cluster in the midwestern United States
    48. A case of imported monkeypox in Singapore
    49. Exportation of monkeypox virus from the African continent
    50. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
    51. The changing epidemiology of human monkeypox—A potential threat? A systematic review
    52. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001
    53. Human monkeypox and smallpox viruses: genomic comparison
    54. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
    55. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy
    56. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention
    57. … of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 …
    58. Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire.
    59. Vaccinating against monkeypox in the Democratic Republic of the Congo
    60. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
    61. monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak
    62. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection
    63. Imported monkeypox, Singapore
    64. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox
    65. Subunit recombinant vaccine protects against monkeypox
    66. Spectrum of infection and risk factors for human monkeypox, United States, 2003
    67. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017–2020
    68. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox
    69. Four generations of probable person-to-person transmission of human monkeypox
    70. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012
    71. Poxvirus dilemmas—monkeypox, smallpox, and biologic terrorism
    72. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis)
    73. monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire.
    74. monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health
    75. monkeypox virus and insights into its immunomodulatory proteins
    76. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection
    77. A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus
    78. monkeypox virus in Nigeria: infection biology, epidemiology, and evolution
    79. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo
    80. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man
    81. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021
    82. Occupational risks during a monkeypox outbreak, Wisconsin, 2003
    83. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus
    84. Emerging diseases—the monkeypox epidemic in the Democratic Republic of the Congo
    85. Ecology and geography of human monkeypox case occurrences across Africa
    86. monkeypox: an epidemiologic and clinical comparison of African and US disease
    87. Detection of human monkeypox in the Republic of the Congo following intensive community education
    88. Smallpox and monkeypox in non-human primates
    89. Outbreaks of human monkeypox after cessation of smallpox vaccination
    90. Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus
    91. Human monkeypox–After 40 years, an unintended consequence of smallpox eradication
    92. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246
    93. A game-theoretic model of monkeypox to assess vaccination strategies
    94. monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity
    95. Fatal monkeypox in wild-living sooty mangabey, Cote d’Ivoire, 2012
    96. In vitro efficacy of ST246 against smallpox and monkeypox
    97. Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003.
    98. Serological survey for human monkeypox infections in a selected population in Zaire.
    99. Intrafamily transmission of monkeypox virus, Central African Republic, 2018
    100. Genomic characterisation of human monkeypox virus in Nigeria
    101. Human monkeypox: current state of knowledge and implications for the future
    102. A phylogeographic investigation of African monkeypox
    103. Human infection with monkeypox virus: laboratory investigation of six cases in West Africa
    104. Experimental infection of prairie dogs with monkeypox virus
    105. monkeypox virus: histologic, immunohistochemical and electron‐microscopic findings
    106. Outbreaks of monkeypox and serological surveys in nonhuman primates
    107. Using remote sensing to map the risk of human monkeypox virus in the Congo Basin
    108. Use of surveillance outbreak response management and analysis system for human monkeypox outbreak, Nigeria, 2017–2019
    109. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005
    110. Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States
    111. Retrospective analysis of monkeypox infection
    112. monkeypox: a review of the history and emergence in the Western hemisphere
    113. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus
    114. Prevalence of antibodies against orthopoxviruses among residents of Likouala region, Republic of Congo: evidence for monkeypox virus exposure
    115. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus
    116. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia
    117. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation
    118. Assessing monkeypox virus prevalence in small mammals at the human–animal interface in the Democratic Republic of the Congo
    119. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques
    120. Comparison of monkeypox Viruses Pathogenesis in Mice by In Vivo Imaging
    121. Strengthening of surveillance during monkeypox outbreak, Republic of the Congo, 2017
    122. Intragenornic sequence transposition in monkeypox virus
    123. Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different
    124. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models
    125. Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005
    126. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus
    127. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers
    128. Human monkeypox–Kasai Oriental, Democratic Republic of…
    129. Epidemiologic and ecologic investigations of monkeypox, Likouala Department, Republic of the Congo, 2017
    130. Notes from the field: Responding to an outbreak of monkeypox using the one health approach—Nigeria, 2017–2018
    131. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response
    132. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo
    133. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease.
    134. Human monkeypox transmitted by a chimpanzee in a tropical rain-forest area of Zaire
    135. monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection
    136. Susceptibility of some rodent species to monkeypox virus, and course of the infection
    137. A nosocomial outbreak of human monkeypox in the Central African Republic
    138. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
    139. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo
    140. Comparison of white pock (h) mutants of monkeypox virus with parental monkeypox and with variola-like viruses isolated from animals
    141. Comparative pathology of smallpox and monkeypox in man and macaques
    142. Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection
    143. US monkeypox outbreak traced to Wisconsin pet dealer
    144. Susceptibility of Marmosets (Callithrix jacchus) to monkeypox Virus: A Low Dose Prospective Model for monkeypox and Smallpox Disease
    145. Whither monkeypox vaccination
    146. Clinical features and management of human monkeypox: a retrospective observational study in the UK
    147. monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan® assays on the Roche LightCycler
    148. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo
    149. monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo
    150. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases
    151. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses
    152. Effects of georeferencing effort on mapping monkeypox case distributions and transmission risk
    153. … kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox …
    154. Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques
    155. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge
    156. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates
    157. Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo
    158. Twelve cases of monkeypox virus outbreak in Bangassou District (Central African Republic) in December 2015
    159. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
    160. Evaluation of the GeneXpert for human monkeypox diagnosis
    161. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus
    162. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease
    163. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA
    164. Enhancing health care worker ability to detect and care for patients with monkeypox in the Democratic Republic of the Congo
    165. Recombinase polymerase amplification assay for rapid detection of monkeypox virus
    166. Human monkeypox in Sierra Leone after 44-year absence of reported cases
    167. Studies on monkeypox virus
    168. Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Aerosolized monkeypox Virus
    169. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria
    170. Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin
    171. Seven monkeypox cases are confirmed in England
    172. Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes
    173. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route
    174. monkeypox virus phylogenetic similarities between a human case detected in Cameroon in 2018 and the 2017-2018 outbreak in Nigeria
    175. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic
    176. monkeypox and whitepox viruses in West and Central Africa
    177. Confidence in managing human monkeypox cases in Asia: A cross-sectional survey among general practitioners in Indonesia
    178. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values
    179. The evolving epidemiology of human monkeypox–questions still to be answered
    180. Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system
    181. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions
    182. Human monkeypox–Kasai Oriental, Zaire, 1996-1997
    183. Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus
    184. Evaluation of monkeypox disease progression by molecular imaging
    185. A Novel International monkeypox Outbreak
    186. monkeypox in a Traveler Returning from Nigeria—Dallas, Texas, July 2021
    187. Mapping monkeypox transmission risk through time and space in the Congo Basin
    188. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge
    189. Case report: Human monkeypox in the kivus, a conflict region of the Democratic Republic of the Congo
    190. monkeypox outbreak a reminder of emerging infections vulnerabilities
    191. Specific detection of monkeypox virus by polymerase chain reaction
    192. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia
    193. Characterization of monkeypox virus infection in African rope squirrels (Funisciurus sp.)
    194. monkeypox—Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era
    195. Molecular evidence of human monkeypox virus infection, Sierra Leone
    196. Ghosts of infections past: using archival samples to understand a century of monkeypox virus prevalence among host communities across space and time
    197. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense …
    198. Evolution of synonymous codon usage bias in west African and central African strains of monkeypox virus
    199. monkeypox virus infections in small animal models for evaluation of anti-poxvirus agents
    200. The histopathology and electron microscopy of a human monkeypox lesion
    201. Epidemiology, Diagnosis, and Control of monkeypox Disease: A comprehensive Review
    202. Inhalational monkeypox virus infection in cynomolgus macaques
    203. monkeypox-specific antibodies in human and simian sera from the Ivory Coast and Nigeria
    204. Inhibition of monkeypox virus replication by RNA interference
    205. Clinical course and outcome of human monkeypox in Nigeria
    206. monkeypox in the United States: an occupational health look at the first cases
    207. Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay
    208. Independent evolution of monkeypox and variola viruses
    209. Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity
    210. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of …
    211. monkeypox disease transmission in an experimental setting: prairie dog animal model
    212. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions
    213. Laboratory Investigations of African Pouched Rats (Cricetomys gambianus) as a Potential Reservoir Host Species for monkeypox Virus
    214. Temporal and spatial dynamics of monkeypox in Democratic Republic of Congo, 2000–2015
    215. Evolution of a disease surveillance system: an increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001–2013
    216. Evidence for recent genetic variation in monkeypox viruses
    217. Comparison of multiplexed immunofluorescence imaging to chromogenic immunohistochemistry of skin biomarkers in response to monkeypox virus infection
    218. Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (smallpox, monkeypox and cowpox)
    219. Three specific antigens produced in vaccinia, variola, and monkeypox infections
    220. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon
    221. Comparison of West African and Congo Basin monkeypox viruses in BALB/c and C57BL/6 mice
    222. In vitro inhibition of monkeypox virus production and spread by Interferon-β
    223. Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes
    224. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal monkeypox Virus Animal Model
    225. Elucidating the role of the complement control protein in monkeypox pathogenicity
    226. monkeypox
    227. Human monkeypox
    228. monkeypox= Orthopoxvirose simienne
    229. Fatal monkeypox in a child in Kikwit, Zaire
    230. Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease
    231. monkeypox outbreak among pet owners
    232. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
    233. monkeypox without exanthem
    234. monkeypox transmission among international travellers—serious monkey business?
    235. Nucleotide sequence of the thymidine kinase gene region of monkeypox and variola viruses
    236. monkeypox Virus
    237. Importance of epidemiological research of monkeypox: is incidence increasing?
    238. Evasion of the innate immune type I interferon system by monkeypox virus
    239. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus
    240. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations
    241. The 2017 human monkeypox outbreak in Nigeria—report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State …
    242. Extensive Lesions of monkeypox in a Prairie Dog (Cynomys sp.)
    243. Can variola-like viruses be derived from monkeypox virus? An investigation based on DNA mapping
    244. Immunological Memory after Exposure to Variola Virusm monkeypox Virus, and Vaccinia Virus
    245. monkeypox virus as a source of whitepox viruses
    246. Learning from experience: the public health response to West Nile virus, SARS, monkeypox, and hepatitis A outbreaks in the United States
    247. A Tale of Two Viruses: Coinfections of monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo
    248. Imported monkeypox from International Traveler, Maryland, USA, 2021
    249. Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber
    250. Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa
    251. Clinical and Epidemiological Findings from Enhanced monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011–2015
    252. Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay
    253. monkeypox spreads as US public-health system plays catch-up
    254. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination
    255. Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess monkeypox Drug Efficacy
    256. monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation
    257. Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African …
    258. The Role of the Obstetrician–Gynecologist in Emerging Infectious Diseases: monkeypox and Pregnancy
    259. EVALUATION OF monkeypox VIRUS INFECTION OF BLACK-TAILED PRAIRIE DOGS (CYNOMYS LUDOVICIANUS) USING IN VIVO BIOLUMINESCENT …
    260. monkeypox rash severity and animal exposures in the Democratic Republic of the Congo
    261. Emergence of human monkeypox in west Africa
    262. monkeypox: What do we know about the outbreaks in Europe and North America?
    263. Serological relatedness of monkeypox, variola, and vaccinia viruses
    264. Comparison of monkeypox virus clade kinetics and pathology within the prairie dog animal model using a serial sacrifice study design
    265. monkeypox: A Neglected Viral Zoonotic Disease
    266. Human monkeypox and other poxvirus infections of man
    267. … tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high-and low-dose monkeypox …
    268. The virion and soluble antigen proteins of variola, monkeypox, and vaccinia viruses
    269. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques
    270. Lay media reporting of monkeypox in Nigeria
    271. Modeling the transmission dynamics of the monkeypox virus infection with treatment and vaccination interventions
    272. Loop‐mediated isothermal amplification‐based diagnostic assay for monkeypox virus infections
    273. Report of monkeypox cases in 2018 in the United Kingdom
    274. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo
    275. Expansion, reexpansion, and recall-like expansion of Vγ2Vδ2 T cells in smallpox vaccination and monkeypox virus infection
    276. Genus Orthopoxvirus: monkeypox virus
    277. Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains
    278. ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification
    279. Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein
    280. Whitepox virus isolated from hamsters inoculated with monkeypox virus
    281. Variola or a severe case of varicella? A case of human variola due to monkeypox virus in a child from the Cameroon
    282. Transmission dynamics of monkeypox virus: a mathematical modelling approach
    283. Attenuation of monkeypox virus by deletion of genomic regions
    284. … with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus …
    285. Further Assessment of monkeypox Virus Infection in Gambian Pouched Rats (Cricetomys gambianus) Using In Vivo Bioluminescent Imaging
    286. monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus
    287. Species-specific differentiation of variola, monkeypox, and varicella-zoster viruses by multiplex real-time PCR assay
    288. monkeypox outbreak diagnostics and implications for vaccine protective effect
    289. … of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox
    290. monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation
    291. Emerging infections and pregnancy: West Nile virus, monkeypox, severe acute respiratory syndrome, and bioterrorism
    292. Orthopoxviruses: vaccinia (smallpox vaccine), variola (smallpox), monkeypox, and cowpox
    293. Generalized monkeypox in orally infected rabbits and white mice
    294. Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey
    295. Cytokine modulation correlates with severity of monkeypox disease in humans
    296. … of D-and L-2-cyclopentenone and their utility for the synthesis of carbocyclic antiviral nucleosides against orthopox viruses (smallpox, monkeypox, and cowpox virus)
    297. PLAQUE MORPHOLOGY OF monkeypox VIRUS AS AN AID TO STRAIN IDENTIFICATION
    298. Multistate outbreak of monkeypox-Illinois, Indiana, and Wisconsin, 2003
    299. Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus
    300. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
    301. Stability analysis for the equilibria of a monkeypox model
    302. monkeypox chez l’homme, 1970-79
    303. Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo
    304. Characterization of Macaque Pulmonary Fluid Proteome during monkeypox Infection
    305. Modelling HIV/AIDS and monkeypox co-infection
    306. … -orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox …
    307. Substrate specificity of homogeneous monkeypox virus uracil-DNA glycosylase
    308. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27
    309. A study of the specificities of sequential antisera to variola and monkeypox viruses by radioimmunoassay
    310. monkeypox in Nigeria: A case report of re-emerged disease outbreak
    311. Toward Understanding the Outcomes of monkeypox Infection in Human Pregnancy
    312. Can culling to prevent monkeypox infection be counter-productive? Scenarios from a theoretical model
    313. Human monkeypox hits beleaguered Zaire
    314. monkeypox in the Democratic Republic of the Congo (former Zaire)
    315. Do monkeypox Exposures Vary by Ethnicity? Comparison of Aka and Bantu Suspected monkeypox Cases
    316. monkeypox virus: responses of infection in chick embryos
    317. Induction, Course, and Transmissibility of monkeypox in the Baboon (Papio cynocephalus)
    318. … of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox …
    319. Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
    320. IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal monkeypox Challenge Prairie Dog …
    321. Identification and whole-genome sequencing of a monkeypox virus strain isolated in Israel
    322. Nucleotide sequence comparison of homologous genomic regions from variola, monkeypox, and vaccinia viruses
    323. monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions
    324. monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1
    325. Assessment of media reportage of monkeypox in southern Nigeria
    326. Emergence of monkeypox—West and Central Africa, 1970–2017
    327. A Case Report of monkeypox in a 4-Year-Old Boy from the DR Congo: Challenges of Diagnosis and Management
    328. Electron-microscopical observations on the development of vaccinia, cowpox and monkeypox viruses in pig skin.
    329. Anticipating smallpox and monkeypox outbreaks: Complications of the smallpox vaccine
    330. Prairie-dog model offers hope of tackling monkeypox virus
    331. Analgesia during monkeypox virus experimental challenge studies in prairie dogs (Cynomys ludovicianus)
    332. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
    333. A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox
    334. Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus
    335. Clinical and epidemiologic findings from enhanced monkeypox surveillance in Tshuapa Province, Democratic Republic of the Congo during 2011–2015
    336. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022
    337. Human monkeypox in Kasai Oriental, Democratic Republic of the Congo (former Zaire): preliminary report of October 1997 investigation
    338. Successful treatment in the monkeypox and variola primate models of smallpox by the oral drug ST-246
    339. Development of prophylactics and therapeutics against the smallpox and monkeypox biothreat agents
    340. Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in Cameroon
    341. monkeypox: features of spread after cancellation of mandatory pox immunization
    342. Monoclonal antibodies to a monkeypox virus polypeptide determinant
    343. Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination
    344. Re-emergence of monkeypox in Nigeria: A cause for concern and public enlightenment
    345. Surveillance, case investigation and contact tracing for monkeypox: interim guidance, 22 May 2022
    346. An adult patient with suspected of monkeypox infection differential diagnosed to chickenpox
    347. The polypeptides of monkeypox virus: I. Analysis of the polypeptide synthesis of MPV by SDS-PAGE and by two-dimensional electrophoresis
    348. A Neuro-Fussy Based Model for Diagnosis of monkeypox Diseases
    349. Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates
    350. monkeypox outbreak diagnostics and implications for vaccine protective effect
    351. Descriptive epidemiology of monkeypox in Nigeria, September 2017–June 2019
    352. In vitro growth characteristics of monkeypox virus
    353. Human monkeypox
    354. … IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus …
    355. monkeypox, Marshfield Clinic and the Internet: leveraging information technology for public health
    356. Finishing monkeypox genomes from short reads: assembly analysis and a neural network method
    357. Unveiling the Arcane of an Elusive Virus from the Heart of the African Continent: The monkeypox
    358. monkeypox virus (MPV) I. Propagation, purification, and further characterization
    359. The monkeypox virus outbreak: Reflections from the frontlines
    360. Increase seen in monkeypox cases
    361. Transmission dynamics of monkeypox virus: a mathematical modelling approach
    362. monkeypox, 1991= Orthopoxvirose simienne, 1991
    363. US doctors investigate more than 50 possible cases of monkeypox
    364. monkeypox multi-country outbreak
    365. [18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of monkeypox Virus Infection
    366. monkeypox detection in maculopapular lesions in two young Pygmies in the Central African Republic
    367. SARS: here to stay? monkeypox: beware of exotic pets.
    368. Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses
    369. Human monkeypox in Kasai Oriental, Zaire (1996-1997)
    370. Reminiscing the recent incidence of monkeypox in Nigeria: Its ecologic-epidemiology and literature review
    371. EARLY WARNING OF monkeypox DISEASE IN INDONESIA
    372. monkeypox and Other Emerging Orthopoxvirus Infections
    373. Human monkeypox in West Africa
    374. Emergence of monkeypox in West Africa and Central Africa, 1970-2017/Emergence de l’orthopoxvirose simienne en Afrique de l’Ouest et en Afrique centrale, 1970 …
    375. KNOWLEDGE AND PERCEPTION OF monkeypox DISEASE IN YENAGOA, BAYELSA STATE
    376. monkeypox virus as a potential source of variola virus
    377. An Early Transmissibility Estimate for the 2022 monkeypox Outbreak
    378. Update: Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003
    379. Sixty seconds on… monkeypox
    380. Training health workers for enhanced monkeypox surveillance, Democratic Republic of the Congo
    381. Human monkeypox in the Democratic Republic of Congo: Presentation, Prediction and Animal Exposures Associated with Rash Severity
    382. The changing epidemiology of human monkeypox—A potential threat? A systematic review| PLOS Neglected Tropical Diseases
    383. Sounding the alarm: Defining thresholds to trigger a public health response to monkeypox
    384. Identification of human pathogenic variola and monkeypox viruses by real-time polymerase chain reaction
    385. Physicians’ willingness to be vaccinated with a smallpox vaccine to prevent monkeypox viral infection: A cross-sectional study in Indonesia
    386. Major Increase in Human monkeypox Incidence 30 Years After Smallpox Vaccination Campaigns Cease in the Democratic Republic of Congo: AW Rimoin et al. PNAS …
    387. CDC information on monkeypox virus
    388. Research progress in monkeypox virus detection
    389. monkeypox Virus
    390. monkeypox virus (MPV) II. Uncoating and nucleic acid synthesis
    391. Triage of a febrile patient with a rash: a comparison of chickenpox, monkeypox, and smallpox
    392. A Case of monkeypox in a Returned Traveler
    393. Correction for Hutson et al.,“Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal monkeypox Virus Animal Model”
    394. Optimization of automated segmentation of monkeypox virus-induced lung lesions from normal lung CT images using hard C-means algorithm
    395. Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques
    396. Modelling human-to-human transmission of monkeypox Addendum
    397. monkeypox= Orthopoxvirose simienne
    398. Modelling human-to-human transmission of monkeypox Supporting information
    399. monkeypox not mutating
    400. monkeypox on the rise
    401. Human monkeypox: update 1978
    402. Scrutinizing surface glycoproteins and poxin-schlafen protein to design a heterologous recombinant vaccine against monkeypox virus
    403. Emerging monkeypox
    404. monkeypox Virus
    405. A game-theoretic model of monkeypox to
    406. monkeypox Virus Hosts and Transmission Routes: A Systematic Review of a Zoonotic Pathogen
    407. Plans to minimize the risk of viral infections–it’s all a matter of susceptibility part II: SARS, West Nile, and monkeypox
    408. HUMAN monkeypox: UPDATE= ORTHOPOXVIROSE SIMIENNE DE L’HOMME: MISE À JOUR
    409. Post-Exposure Vaccination with a Highly Attenuated Vaccinia Vaccine, LC16m8, for Protection of Nonhuman Primates from monkeypox
    410. Patient safety tools: SARS, smallpox, monkeypox, and avian flu
    411. On alert for monkeypox
    412. An Outbreak of monkeypox in Doedain District, Rivercess County, Liberia, June, 2017
    413. Human monkeypox, A Newly
    414. High acceptance of new monkeypox vaccine among GPs in Indonesia
    415. Generation and characterization of specific monoclonal antibodies against monkeypox virus
    416. Early Release-Reemergence of Human monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020
    417. The World Health Organization’s monkeypox surveillance programme, 1980-86
    418. First US monkeypox cases crop up in the Midwest
    419. Descriptive epidemiology of monkeypox outbreak in Bayelsa State South-South Nigeria, November 2017
    420. Emergence of monkeypox in West and Central Africa, 1970–2017–Émergence de l’orthopoxvirose simienne en Afrique de l’Ouest et en Afrique centrale, 1970 …
    421. Human monkeypox and Human Immunodeficiency Virus Co-infection: A Case Series in Makurdi, Benue State, Nigeria
    422. Interim Case Definition for Animal Cases of monkeypox
    423. Design and optimization of a monkeypox virus specific serological assay
    424. RESEARCH monkeypox Transmission and Pathogenesis in Prairie Dogs
    425. Human monkeypox in the Kivus, a conflict region of The Democratic Republic of the Congo
    426. A COMPARATIVE ANALYSIS OF monkeypox AND VARIOLA VIRUS DNA (VIRUS).
    427. Le virus monkeypox et whitepox en Afrique occidentale et centrale
    428. Mapping monkeypox Transmission Risk through Time and Space in the Congo
    429. Ecological Niche and Geographic Distribution of Human monkeypox in
    430. Human monkeypox in the US: investigations confirm that multiple animal species are susceptible to infection
    431. Proteomic Basis of the Antibody Response to monkeypox Virus Infection Examined in
    432. US monkeypox outbreak traced to Wisconsin pet dealer.(Infectious Diseases)
    433. Comparative study of variola virus and monkeypox virus interferon-gamma-binding
    434. Ocular complications associated with acute monkeypox virus infection, DRC
    435. Generalized monkeypox in young rabbits and white mice infected orally.
    436. An Investigation into the Historical Distribution, Prevalence, and Host Community of monkeypox Virus (MPXV) Among Funisciurus Museum Skin Specimens …
    437. Orthopoxviruses: Variola, Vaccinia, Cowpox, and monkeypox
    438. Report on the 2003 Outbreak of monkeypox in the Western Hemisphere
    439. SMALLPOX: POST-ERADICATION SURVEILLANCE: First isolation of monkeypox virus from a wild animal infected in nature
    440. Analysis of the complete genomes of rabbitpox virus utrecht and three West African isolates of monkeypox virus
    441. … COMPARATIVE MOLECULAR BIOLOGY BETWEEN AN ONCOGENIC POXVIRUS (YABA) AND AN ORTHOPOXVIRUS (monkeypox)(PROTEINS, DNA, CLONING) …
    442. A One Health Perspective on Disease Dynamics: Human monkeypox Transmission in Sankuru District, Democratic Republic of Congo
    443. Rapid Identification of monkeypox Virus using Tandem Repeats with Insertion, Deletion and SNPs
    444. SMALLPOX: POST-ERADICATION SURVEILLANCE: Squirrels proved to maintain monkeypox virus transmission in nature
    445. Smallpox, vaccinia and human monkeypox viruses
    446. Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling re…
    447. Communication with the Public in Outbreaks of West Nile Virus, SARS, monkeypox, and Hepatitis A in the United St…
    448. Public Health Assessment in Outbreaks of West Nile Virus, SARS, monkeypox, and Hepatitis A in the United States
    449. monkeypox detection in rodents using real-time 3’minor groove binder Taqman assays on the Roche LightCycler, Laboratory Investigation 84: 1200-1208
    450. Utilization of the prairie dog (Cynomys sp.) animal model for the study of monkeypox virus: pathogenicity differences between viral clades and the effect of …
    451. monkeypox virus infection of rhesus macaques induces massive expansion of NK cells, but suppresses NK cell function (P4369)
    452. Correction to Comparative Proteomics of Human monkeypox and Vaccinia Intracellular Mature and Extracellular Enveloped Virions
    453. COS 88-9: monkeypox in the Democratic Republic of Congo: Transmission dynamics of a re-emerging zoonosis
    Share
    0
    INTERSTELLAR BLEND

    Related posts

    June 1, 2022

    STEM CELL THERAPY


    Read more
    June 1, 2022

    PHYTOCHEMICALS


    Read more
    June 1, 2022

    SMALLPOX


    Read more

    Comments are closed.

    Recent Posts

    • STEM CELL THERAPY
    • PHYTOCHEMICALS
    • SMALLPOX
    • ELLAGIC ACID
    • CYANIDIN
    © 2022 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!